Eleison Pharmaceuticals Inc. (ELSN)

Eleison Pharmaceuticals Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	1.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-14.08

Financial Efficiency

Return on equity (ROE) is -905.62% and return on invested capital (ROIC) is -153.36%.

Return on Equity (ROE)	-905.62%
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	-153.36%
Revenue Per Employee	$500,000
Profits Per Employee	-$2.30M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (1Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (30 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ELSN had revenue of $1.00 million and -$4.59 million in losses.

Revenue	1.00M
Gross Profit	1.00M
Operating Income	-1.47M
Pretax Income	-4.59M
Net Income	-4.59M
EBITDA	-3.17M
EBIT	-3.17M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has $1.83 million in cash and $516,271 in debt, giving a net cash position of $1.31 million.

Cash & Cash Equivalents	1.83M
Total Debt	516,271
Net Cash	1.31M
Net Cash Per Share	n/a
Equity / Book Value	440,785
Book Value Per Share	n/a
Working Capital	707,950

Cash Flow

Operating Cash Flow	-9.01M
Capital Expenditures	n/a
Free Cash Flow	-9.01M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -146.78% and -459.09%.

Gross Margin	100.00%
Operating Margin	-146.78%
Pretax Margin	-459.09%
Profit Margin	-459.09%
EBITDA Margin	-316.78%
EBIT Margin	-316.78%
FCF Margin	-901.21%

Dividends & Yields

ELSN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a